AAOpt 2025: Narrowing down the cause of the infamous dizziness symptom | Optometry Times - Clinical News

Published on October 17, 2025
Continue reading on website
Other news

Smartlens Secures $5.2 Million in Bridge Funding, Marked for FDA Clearance and Market Launch Efforts

October 17, 2025
SUNNYVALE, Calif.—Smartlens, Inc., a clinical-stage ophthalmic technology company advancing next-generation glaucoma management devices, has announced the closing of an oversubscribed $5.2 million bridge round led by Ambit Health Ventures. The financing will be used to advance the FDA clearance process and prepare for an expedited market launch of the company’s miLens product following clearance,

Waist Index May Serve as Novel Metric for DR

October 17, 2025
DR development has established determinants like elevated blood pressure and inadequate glycemic control, with growing research indicating obesity or being overweight itself is a major contributor to diabetes-related complications. In this study, the relationship between weight-adjusted waist index and women was particularly strong. Photo: Lei J, et al. Medicine. 2025;104(41):e45110. Click image t